-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Qj9Ok8/omO59ZIQ5Cu6ndWqr4RDpM7sZ/ElVyelbMgQMlInBJRWETp3hpGeKGm9n IFYlaQ+fHRWOnH1Pz93q0w== 0000945769-10-000006.txt : 20100119 0000945769-10-000006.hdr.sgml : 20100118 20100119104639 ACCESSION NUMBER: 0000945769-10-000006 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100115 FILED AS OF DATE: 20100119 DATE AS OF CHANGE: 20100119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SELTZER REUBEN CENTRAL INDEX KEY: 0001142334 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-20424 FILM NUMBER: 10532281 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HI TECH PHARMACAL CO INC CENTRAL INDEX KEY: 0000887497 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 112638720 STATE OF INCORPORATION: NY FISCAL YEAR END: 0430 BUSINESS ADDRESS: STREET 1: 369 BAYVIEW AVENUE CITY: AMITYVILLE STATE: NY ZIP: 11701 BUSINESS PHONE: 5167898228 MAIL ADDRESS: STREET 1: 369 BAYVIEW AVE. CITY: AMITYVILLE STATE: NY ZIP: 11701 4 1 edgar.xml PRIMARY DOCUMENT X0303 4 2010-01-15 0000887497 HI TECH PHARMACAL CO INC HITK 0001142334 SELTZER REUBEN C/O HI-TECH PHARMACAL CO., INC. 369 BAYVIEW AVENUE AMITYVILLE NY 11701 1 0 0 0 Common Stock 2010-01-15 4 M 0 26250 1.78 A 519785 D Common Stock 2010-01-15 4 S 0 26250 25.70 D 493535 D Common Stock 299203 I By Spouse and Issue Stock Option (Right to Buy) 1.78 2010-01-15 4 M 0 26250 0 D 2001-06-01 2010-06-01 Common Stock 26250 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.55 to $25.77, inclusive. The reporting person undertakes to provide Hi-Tech Pharmacal Co., Inc., any security holder of Hi-Tech Pharmacal Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) of this Form 4. Stock Option granted under Hi-Tech Pharmacal Co., Inc.'s Amended and Restated Stock Option Plan, which is a Rule 16b-3 Plan. The option became exercisable in four (4) equal annual installments beginning on the first anniversary of the grant date. Other than the option reflected on this form as exercised by the filer, the filer is also the holder of additional options to acquire 210,000 shares of the Company's stock. The additional options were granted on various dates, with varying exercise prices and exercisable and expiration dates. Reuben Seltzer 2010-01-18 -----END PRIVACY-ENHANCED MESSAGE-----